Please try another search
Palatin Technologies, Inc., a biopharmaceutical company, develops targeted receptor-specific therapeutics for the treatment of various diseases in the United States. The company’s lead product is Vyleesi, a melanocortin receptor (MCr) agonist for the treatment of premenopausal women with hypoactive sexual desire disorder. It is also developing oral PL8177, a selective MC1r agonist peptide that is in Phase 2 clinical trial for the treatment of inflammatory bowel diseases. In addition, the company engages in the development of PL9643, a peptide melanocortin agonist active at multiple MCrs, including MC1r and MC5r for anti-inflammatory ocular indications, such as dry eye disease, which is in Phase 3 clinical trial; and melanocortin peptides for diabetic retinopathy. Further, it is developing PL8177, an oral peptide formulation for treatment of ulcerative colitis, which entered Phase 2 clinical trials. The company was founded in 1986 and is based in Cranbury, New Jersey.
Name | Age | Since | Title |
---|---|---|---|
J. Stanley Hull | 70 | 2005 | Independent Director |
Robert K. deVeer | 76 | 1998 | Independent Director |
Carl Spana | 60 | 1996 | Co-Founder, President, CEO & Director |
John K. A. Prendergast | 68 | 1996 | Independent Non-Executive Chairman |
Alan W. Dunton | 68 | 2011 | Independent Director |
Michael A. Perelman | - | - | Member of Female Sexual Dysfunction Expert Panel |
Raymond C. Rosen | - | - | Member of Female Sexual Dysfunction Expert Panel |
James Pfaus | - | - | Member of Female Sexual Dysfunction Expert Panel |
Murray Freedman | - | - | Member of Female Sexual Dysfunction Healthcare Provider Expert Panel |
Lisa Larkin | - | - | Member of Female Sexual Dysfunction Healthcare Provider Expert Panel |
Arlene M. Morris | 70 | 2015 | Independent Director |
Stanley E. Althof | - | - | Member of Female Sexual Dysfunction Expert Panel |
Sharon J. Parish | - | - | Member of Female Sexual Dysfunction Expert Panel |
Ricki Pollycove | 67 | - | Member of Female Sexual Dysfunction Healthcare Provider Expert Panel |
Risa Kagan | - | - | Member of Female Sexual Dysfunction Healthcare Provider Expert Panel |
Martin Miner | - | - | Member of Female Sexual Dysfunction Healthcare Provider Expert Panel |
Anthony M. Manning | 60 | 2017 | Independent Director |
Brooke M. Faught | - | - | Member of Female Sexual Dysfunction Healthcare Provider Expert Panel |
Anita H. Clayton | - | - | Member of Female Sexual Dysfunction Expert Panel |
Sheryl A. Kingsberg | - | - | Member of Female Sexual Dysfunction Expert Panel |
Susan G. Kornstein | - | - | Member of Female Sexual Dysfunction Healthcare Provider Expert Panel |
Cindy M. Meston | - | - | Member of Female Sexual Dysfunction Expert Panel |
Susan Kellogg-Spadt | - | - | Member of Female Sexual Dysfunction Healthcare Provider Expert Panel |
Leonard R. Derogatis | - | - | Member of Female Sexual Dysfunction Expert Panel |
Robin Kroll | - | - | Member of Female Sexual Dysfunction Healthcare Provider Expert Panel |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review